Wound Infiltration as Part of an Opioid Free Pain Management Pathway Following Cesarean Delivery



Status:Not yet recruiting
Conditions:Post-Surgical Pain
Therapuetic Areas:Musculoskeletal
Healthy:No
Age Range:18 - 55
Updated:8/31/2018
Start Date:September 17, 2018
End Date:November 1, 2018
Contact:Nisha Lakhi, MD
Email:NLAKHI@RUMCSI.org
Phone:718-818-2109

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Randomized Control Trial for an Opioid Free Analgesic Pathway Post Cesarean Delivery

This study will investigate the effect of three types of wound infiltration on post Cesarean
opioid analgesia consumption when used in conjunction with an opioid free postoperative
analgesia pathway.

The subjects that meet the inclusion criteria of the study will be randomized preoperatively
into three arms following a 1:1:1 ratio. During the intraoperative course one of three
combinations of wound infiltration will be administered to subjects prior to the closure of
the surgical incision. Subjects in Group I will receive a placebo of normal saline. Subjects
in Group II will receive bupivacaine alone. Subjects in Group III will receive both
bupivacaine and dexmedetomidine.

Inclusion Criteria:

- All scheduled Cesarean deliveries with intrathecal or epidural anesthesia

Exclusion Criteria:

- Emergency Cesarean deliveries

- Multifetal gestation

- Subjects <18 years old

- Subjects belonging to a vulnerable population (including subjects with a known opioid
addiction, subjects with a history of mental illness and prisoners)

- Cesarean delivery with general anesthesia

- Known allergy or hypersensitivity to any of the study medications

- Subjects that can't comprehend the visual analog scale for quantitative pain
assessment
We found this trial at
1
site
Richmond University Medical Center
Staten Island, New York 10310
?
mi
from
Staten Island, NY
Click here to add this to my saved trials